Industry Leader Finds 250 Percent Increased Likelihood of Remission for Patients Who Engage In Data-Driven Treatment
Crossroads Treatment Centers Publishes White Paper Showing Improved Outcomes Through Measurement-Based Care
Crystal Fuller Morley
VP Marketing and Communications
cmorley@ctc.care
Mandi Kane
Associate Vice President
mkane@jarrardinc.com
Crossroads Treatment Centers (Crossroads), is proud to announce the release of a comprehensive white paper exploring the principles of measurement-based care (MBC) and its application in the treatment of Substance Use Disorder (SUD). MBC is an evidence-based approach that leverages data collection and analysis to guide treatment decisions and drive positive patient outcomes. The release of this white paper is an exciting development that underscores Crossroads’ commitment to advancing SUD treatment through data-driven best practices.
“Measurement-based care has been transformative in our approach to treating patients and monitoring their progress through their recovery journeys,” said Dr. Rupert McCormac, Founder and CEO of Crossroads. “We are proud to share how we utilize evidence-based practices to provide our teams with real time insights that allow them to truly individualize patient care and make decisions that support sustained recovery.”
The findings detailed in Crossroads’ white paper reveal that patients who engage in MBC are 2.5 times more likely to achieve remission. Since implementing MBC tools, Crossroads has collected more than 1.4 million patient screens, enabling providers to identify high-risk patients and quickly connect them with the resources they need. Additionally, response times have been shown to be reduced by up to 50 percent, as MBC consistently allows for more patient interaction and active patient involvement in their care.
Crossroads’ approach utilizes both remote and on-site MBC patient screenings to provide treatment teams with real-time access to critical data. Using multiple assessment tools, Crossroads gathers quantitative insights from patient screenings that guide the development of care plans to address patients’ unique needs and evolve with their progress. This data-driven approach offers an objective measure of each patient’s recovery journey and empowers providers to make timely adjustments to care plans that promote long-lasting recovery.
By integrating MBC into the care approach, Crossroads is redefining SUD treatment and providing patients with data-driven, tailored support to enhance outcomes at every stage of recovery.
To access the full white paper, visit Measurement-Based Care for Patients with Substance Use Disorder - Crossroads Treatment Centers.
About Crossroads Treatment Centers
Since 2005, Crossroads has been at the forefront of treating patients with substance use disorder (SUD). Currently operating 100+ centers across nine states, we are a family of doctors, nurse practitioners, counselors and professionals dedicated to providing the most accessible and highest quality treatment options to combat the growing substance use epidemic. We create individualized treatment plans that use evidence-based medication-assisted treatment and behavioral health therapies to help those with SUD pave their paths to recovery. The outcomes are often lifesaving and lead to significantly improved lives for our patients, their families and their communities.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241029725100/en/
